Summary
The effect of yohimbine on a response to nociceptive stimulation mediated by supraspinal structures was studied after subcutaneous administration in doses from 0.25 mg/kg up to 25 mg/kg. The results showed that to describe adequately the dose-response relationship of yohimbine in pain modulation, characteristics of opposing effects had to be considered: low doses with an ED50-value of 0.56 mg/kg were found to dose-dependently facilitate nociception whereas high doses instead induced antinociception with an ED50 of 4.74 mg/kg. The possible capacity of α2-adrenoceptors to modulate responses to nociception is discussed.
Similar content being viewed by others
References
Abdel Rahman A-RA, Sharabi FM (1981) Presynaptic alpha receptors in relation to the cardiovascular effect of yohimbine in the anesthetized cat. Arch Int Pharmacodyn 252:229–240
Andén NE, Strömbom U (1974) Adrenergic receptor blocking agents: Effects on central noradrenaline and dopamine receptors and on motor activity. Psychopharmacology 38:91–101
Andén NE, Grabowska M (1976) Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain. Eur J Pharmacol 39:275–282
Andén NE, Grabowska M, Strömbom U (1976) Different α-receptors in central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedeberg's Arch Pharmacol 292:43–52
Bodnar RJ, Ackermann RF, Kelly DD, Glusmann M (1978) Elevations in nociceptive thresholds following locus coeruleus lesions. Brain Res Bull 3(2):125–130
Borowski E, Starke K, Ehrl H, Endo T (1977) A comparison of pre- and postsynaptic effects of α-adrenolytic drugs in the pulmonary artery of the rabbit. Neuroscience 2:285–296
Carroll MN, Lim RKS (1960) Observations on the neuropharmacology of morphine and morphine like analgesia. Arch Int Pharmacodyn 125:383–403
Cedarbaum JM, Aghajanian GK (1976) Noradrenergic neurons of the locus coeruleus: Inhibition by epinephrine and activation by the α-antagonist piperoxane. Brain Res 112: 413–419
Cedarbaum JM, Aghajanian GK (1978) Activation of locus coeruleus neurons by peripheral stimuli: Modulation by a collateral inhibitory mechanisms. Life Sci 23:1383–1392
Chance WT, Schechter MD (1979) Autoanalgesia: Blockade by yohimbine. Eur J Pharmacol 58:89–90
Cicero TJ, Meyer ER, Smithloff ER (1974) Alpha adrenergic blocking agents: Antinociceptive activity and enhancement of morphine-induced analgesia. J Pharmacol Exp Ther 189:72–82
Dennis SG, Melzack R, Gutman S, Boucher F (1980) Pain modulation by adrenergic agents and morphine as measured by three pain tests. Life Sci 26:1247–1259
Fielding S, Wilker J, Hynes M, Szewczak M, Novick Jr WJ, Lal H (1978) A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions. J Pharmacol Exp Ther 207:899–905
Hedler L, Stamm G, Weitzell R, Starke K (1981) Functional characterization of central α-adrenoceptors by yohimbine diastereomers. Eur J Pharmacol 70:43–52
Hoffmeister F (1968) Effects of psychotropic drugs on pain. In: Soulairac A, Cahn J, Charpentier J (eds) Pain. Academic Press, London New York, pp 309–319
Hofford NHG, Sheiner LB (1981) Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 6:429–453
Korf J, Bunney BS, Aghjanian GK (1974) Noradrenergic neurons: Morphine inhibition of spontaneous activity. Eur J Pharmacol 25:165–169
Kuraishi Y, Harada Y, Takagi H (1979) Noradrenaline regulation of paintransmission in the spinal cord mediated by α-adrenoceptors. Brain Res 174:333–336
Lineberry CG (1981) Laboratory animals in pain research. In: Gay WI (ed) Methods in animal experimentation, vol VI. Academic Press Inc, London New York, pp 256–262
McCleary PE, Leander DJ (1981) Clonidine analgesia and suppression of operant responding: Dissociation of mechanism. Eur J Pharmacol 69:63–69
Paalzow L (1974) Analgesia produced by clonidine in mice and rats. J Pharm Pharmacol 26:361–363
Paalzow G (1976) The potential role of catecholamines in drug induced changes of central pain responses, with special emphasis on morphine effects in the rat. Doctorial Dissertation. Acta Universitatis Upsaliensis 9
Paalzow G, Paalzow L (1973) The effects of caffeine and theophylline on nociceptive stimulation in the rat. Acta Pharmacol Toxicol 32:22–32
Paalzow G, Paalzow L (1976a) Clonidine antinociceptive activity: Effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 292:119–126
Paalzow G, Paalzow L (1976b) Evaluation of the antinociceptive effects of 4,α-dimethyl-m-tyramine (H 77/77) in the rat. Eur J Pharmacol 36:321–329
Paalzow G, Paalzow L (1982) Separate noradrenergic receptors could mediate clonidine induced antinociception. J Pharmacol Expl Ther 223:795–800
Papeschi R, Theiss P (1975) The effect of yohimbine on the turnover of brain catecholamines and serotonin. Eur J Pharmacol 33:1–12
Papeschi R, Sourkes TL, Youdim MBH (1971) The effect of yohimbine on brain serotonin metabolism, motor behavior and body temperature of the rat. Eur J Pharmacol 15:318–326
Reddy SVR, Maderdrut JL, Yaksh TL (1980) Spinal cord pharmacology of adrenergic agonist-mediated antinociception. J Pharmacol Exp Ther 213:525–533
Ruffolo RR, Waddell JE, Yaden EL (1981) Postsynaptic alpha adrenergic receptor subtypes differentiated by yohimbine in tissues from the rat. Existence of alpha-2 adrenergic receptors in rat aorta. J Pharmacol Exp Ther 217:235–240
Sanghvi I, Gershon S (1974) Yohimbine: Behavioral and biochemical effects in mice. Arch Int Pharmacodyn Ther 210:108–120
Scatton B, Zivkovic B, Dedek J (1980) Antidopaminergic properties of yohimbine. J Pharmacol Exp Ther 215:494–499
Schmitt H, LeDouarec L-D, Petillot N (1974) Antinociceptive effects of some α-sympathomimetic agents. Neuropharmacology 13:289–293
Shepperson NB, Duval N, Massingham R, Langer SZ (1981) Pre- and postsynaptic alpha adrenoceptor selectivity studies with yohimbine and its two diastereo-isomers rauwolscine and corynanthine in the anesthetized dog. J Pharmacol Exp Ther 219:540–546
Sokal RR, Rohlf FJ (1969) Biometry. WH Freemann and Comp, San Francisco
Spiehler VR, Randall LO (1979) Agonist-antagonist properties of phenoxy-benzamine in antinociception and opiate dependence tests. Eur J Pharmacol 55:389–395
Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:2–124
Starke K, Montel H (1973) Involvement of α-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones. Neuropharmacology 12:1073–1080
Starke K, Borowski E, Endo T (1975) Preferential blockade of presynaptic α-adrenoceptors by yohimbine. Eur J Pharmacol 34:385
Svensson TH, Bunney BS, Aghajanian GK (1975) Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res 92:291–306
Wagner JG (1975) In: Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton, Ill, p 317
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Paalzow, G.H.M., Paalzow, L.K. Yohimbine both increases and decreases nociceptive thresholds in rats: Evaluation of the dose-response relationship. Naunyn-Schmiedeberg's Arch. Pharmacol. 322, 193–197 (1983). https://doi.org/10.1007/BF00500764
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00500764